Published in Medical Letter on the CDC and FDA, March 25th, 2007
RISPERDAL(R) is approved in the U.S. to treat acute manic or mixed episodes of Bipolar I Disorder and for the treatment of schizophrenia in adults. It is marketed by Janssen, L.P.
In October 2006, RISPERDAL(R) was also approved in the U.S. for the treatment of irritability associated with autistic disorder, including symptoms of aggression...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA